Oslo University Hospital HF — Sponsor Intelligence | 75 EU Trials

Filter these 75 trials by condition, phase, country and more.

Open in Search →

75 Registered trials

35 Recruiting

28 Completed trials

20 Countries active

142 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 12 Phase II/III: 4 Phase II: 30 Phase I/II: 5 Phase III/IV: 1 Phase IV: 18 Phase I: 2 Phase I (Other): 2 Phase I (FiH): 1

Oversight events:

4 serious breaches 11 temporary halts 4 urgent safety measures across 7 trials

View oversight register →

100%

28 of 28 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Glioblastoma 3 Glioblastoma multiforme 2 Ischaemic stroke 2 Heart disease congenital 1 Pleural mesothelioma malignant 1 Aortic stenosis 1 Follicle centre lymphoma follicular grade I II III 1 Mitral valve prolapse 1 Colorectal cancer metastatic 1 Malignant melanoma stage III 1 Soft tissue sarcoma 1 Breast cancer 1

Top IMPs

SODIUM CHLORIDE 9 DEXAMETHASONE 4 MYCOPHENOLATE MOFETIL 3 NIVOLUMAB 3 TACROLIMUS 3 ATEZOLIZUMAB 2 BEVACIZUMAB 2 DABRAFENIB 2 FLOXURIDINE 2 GEMCITABINE 2 NEPAFENAC 2 OXYTOCIN SYNTHETIC 2

All trials

75 total

Treatment of frontal fibrosing alopecia with microneedling and photodynamic therapy Pending

2023-506974-11-00 Phase II 1 country METHYL AMINOLEVULINATE HYDROCHLORIDE
An exploratory phase II study aimed to detect long term changes in volume of port-wine macrocheilia and color of port-wine stain in patients… Pending

2024-511937-37-01 Phase II 1 country SIROLIMUS
Intranasal oxytocin in youth with autism Pending

2024-512387-56-00 Phase II 1 country OXYTOCIN SYNTHETIC; SODIUM CHLORIDE
ZAMBA: Zoledronic Acid for Modic Back Pain. Pending

2024-517345-14-00 Phase III 1 country SODIUM CHLORIDE; ZOLEDRONIC ACID
A Phase I/IIa study to assess the safety and biological activity of TdT-3, an autologous TCR T-cell therapy targeting TdT, in HLA-A*02:01+ p… Pending

2024-519320-24-00 Phase I (FiH) 1 country TDT-3
LASER volunteer trial: Local Anaesthetic Systemic Effect during Regional anaesthesia procedures Pending

2025-520910-67-01 Phase IV 1 country
A randomized placebo-controlled double-blind trial phase II two-arm study to investigate infarct growth over 72 hours assessed with diffusio… Pending

2025-521269-28-00 Phase II 1 country SODIUM CHLORIDE; TOCILIZUMAB
Icatibant for Propofol Injection Pain Pending

2025-521354-42-00 Phase II 1 country PROPOFOL; SODIUM CHLORIDE
Reassessment of statin-associated muscle symptoms in adults with familial hypercholesterolemia Pending

2025-521589-83-00 Phase IV 1 country ATORVASTATIN
TARGET-EBV in MS: Targeting Epstein Barr Virus with Tenofovir Alafenamide Fumarate in multiple sclerosis Pending

2025-522140-40-00 Phase II 1 country
OmaMig Pilot Pending

2025-522448-41-00 Phase II 1 country OMALIZUMAB
Individualized Intrathecal Chemotherapy Based on Measurement of Brain Fluid Clearance in Pediatric Patients Pending

2025-522453-20-00 Phase II 1 country GADOBUTROL
A randomized controlled phase II, double blinded trial to investigate pulmonary function after treatment with rituximab compared to placebo … Recruiting

2024-517667-23-00 Phase II 4 countries RITUXIMAB; SODIUM CHLORIDE
Cataract surgery and Inflammation – the role for preoperative NSAIDs (pre-CIN) Recruiting

2024-512268-77-00 Phase IV 1 country DEXAMETHASONE; NEPAFENAC
TENECTEPLASE IN CENTRAL RETINAL ARTERY OCCLUSION STUDY (TenCRAOS): A Prospective, randomised-controlled, double-dummy, double-blind phase 3 … Recruiting

2024-517606-29-00 Phase III 6 countries ACETYLSALICYLIC ACID; SODIUM CHLORIDE
A Phase 2, Randomized, Double-Blind, Double-Dummy Study Evaluating the Efficacy, Safety and Biomarkers Effect of ILB® versus Riluzole in par… Recruiting

2024-513927-18-00 Phase II 1 country DEXTRAN SULFATE LOW MOLECULAR WEIGHT; RILUZOLE
A randomized, placebo-controlled, double-blind, 3-period cross-over study in youth with autism spectrum disorders evaluating neural plastici… Recruiting

2023-506826-36-00 Phase II 1 country OXYTOCIN SYNTHETIC; SODIUM CHLORIDE
Frozen shoulder – can physiotherapy improve the outcome? Recruiting

2024-519728-26-00 Phase IV 1 country
PSEUDOVAX – A CANCER VACCINE TARGETING MUTATED GNAS COMBINED WITH IMMUNE CHECKPOINT INHIBITION FOR PATIENTS WITH PSEUDOMYXOMA PERITONEI Recruiting

2024-517047-30-01 Phase I 1 country MOLGRAMOSTIM; PSEUDOVAX HYDROCHLORIDE; TISLELIZUMAB
The Nordic Chronic Migraine Trial of CGRP monoclonal antibody and onabotulinumtoxin A dual therapy – a randomized-controlled double-blind tr… Recruiting

2024-517981-40-00 Phase III 1 country BOTULINUM TOXIN TYPE A; ERENUMAB; FREMANEZUMAB; GALCANEZUMAB; SODIUM CHLORIDE
Anticoagulation with apixaban in venous malformations Recruiting

2024-511930-11-00 Phase II 1 country APIXABAN
Precision cancer medicine in hard-to-treat rare cancers - repurposing drugs in earlier lines of treatment - MATRIX-RARE. Recruiting

2024-513779-42-02 Phase II 1 country DABRAFENIB; IVOSIDENIB; TEMOZOLOMIDE; TISLELIZUMAB; TRAMETINIB; VORASIDENIB
Thrombolysis in Factor Xa-inhibitors Trial (SIFT) Recruiting

2023-509907-34-01 Phase III 3 countries
A pilot study of enalapril in venous malformations Recruiting

2023-510076-31-00 Phase II 1 country ENALAPRIL MALEATE

Showing 1–24 of 75 trials

← All sponsors A–Z